Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Mantle Cell Lymphoma”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Testing effectiveness (Phase 2)Looking for participantsNCT05861050
What this trial is testing

Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma

Who this might be right for
Blastoid Variant Mantle Cell LymphomaMantle Cell LymphomaPleomorphic Variant Mantle Cell Lymphoma
City of Hope Medical Center 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04115631
What this trial is testing

A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Liver LymphomaMantle Cell Lymphoma
ECOG-ACRIN Cancer Research Group 360
Not applicableUnknownNCT05429918
What this trial is testing

Ibrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged ≤65 Years

Who this might be right for
Mantle Cell Lymphoma
Peking University Third Hospital 60
Not applicableWithdrawnNCT00110006
What this trial is testing

Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Case Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT01880567
What this trial is testing

Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
CCND1 PositiveCCND2 PositiveCCND3 Positive+4 more
M.D. Anderson Cancer Center 113
Testing effectiveness (Phase 2)Active Not RecruitingNCT06504199
What this trial is testing

Obinutuzumab, Zanubrutinib, and Lenalidomide Followed Short-Cycle of Obinutuzumab and Cytarabine in Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 39
Testing effectiveness (Phase 2)Study completedNCT01527149
What this trial is testing

Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Stage I Mantle Cell LymphomaStage II Contiguous Mantle Cell LymphomaStage II Non-Contiguous Mantle Cell Lymphoma+2 more
Roswell Park Cancer Institute 37
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06255704
What this trial is testing

A Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle CellLymphoma Patients

Who this might be right for
Mantle Cell Lymphoma
Shanxi Province Cancer Hospital 23
Testing effectiveness (Phase 2)Study completedNCT00376961
What this trial is testing

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT01661881
What this trial is testing

Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Christine Ryan 23
Not applicableLooking for participantsNCT05506410
What this trial is testing

A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Newly Diagnosed Mantle Cell Lymphoma
Zhengzhou University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03710772
What this trial is testing

Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Looking for participantsNCT05245656
What this trial is testing

A Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Kim, Seok Jin 90
Testing effectiveness (Phase 2)Study completedNCT00003311
What this trial is testing

Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT04624958
What this trial is testing

Zanubrutinib and Rituximab Followed by R-DHAOx Then Maintenance with Zanubrutinib for Newly-Diagnosed MCL

Who this might be right for
Mantle Cell LymphomaNewly-diagnosed Mantle Cell Lymphoma
Sun Yat-sen University 42
Large-scale testing (Phase 3)WithdrawnNCT04849715
What this trial is testing

Parsaclisib, a PI3Kδ Inhibitor, in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Incyte Corporation
Testing effectiveness (Phase 2)UnknownNCT03616782
What this trial is testing

Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL)

Who this might be right for
Mantle Cell Lymphoma
Ho Sup Lee 98
Testing effectiveness (Phase 2)Looking for participantsNCT06136351
What this trial is testing

The Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Lymphoma, Mantle-Cell
Ruijin Hospital 23
Load More Results